Performance analysis of Bone Biologics (BBLG)
Annual Return
Over the past 3 years, BBLG has had an average annual return of -74.38%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, BBLG has had an average annual return of -83.88%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, BBLG has had an average annual return of -58.11%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Mar 31, 2016, BBLG has had an average annual return of -56.22%, underperforming the benchmark SPY, which returned +15.19% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -80.00% | -78.26% | -91.00% | -94.05% | -53.07% | +87.51% | -84.62% | +1,055.52% | -43.75% | -2.44% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +50% | -33.33% | +0% | +0% | +0% | +0% | +0% | +0% | |||||
| 2025 | +10% | -18.18% | -11.11% | -12.50% | +28.57% | -22.22% | -28.57% | -20.00% | +25% | -20.00% | -25.00% | -33.33% | -80.00% |
| 2024 | -19.57% | -32.43% | -12.00% | -27.27% | +6.25% | -29.41% | +83.33% | -36.36% | +57.14% | -36.36% | -14.29% | -16.67% | -78.26% |
| 2023 | +34.83% | +4.35% | -12.38% | +0.63% | -34.86% | -71.91% | -10.34% | -47.12% | +5.45% | -25.86% | -23.26% | +39.39% | -91.00% |
| 2022 | -39.20% | -14.96% | +52.74% | -21.58% | -27.29% | -11.67% | -8.58% | +4.68% | -21.63% | -57.13% | -33.42% | -30.10% | -94.05% |
| 2021 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | -33.34% | -27.40% | -3.04% | -53.07% |
| 2020 | +0% | +0% | +0% | +0% | -25.00% | +0% | -16.66% | +109.99% | +42.86% | +87.51% | |||
| 2019 | -61.54% | +0% | -15.00% | -52.94% | -84.62% | ||||||||
| 2018 | -55.56% | +13.12% | +164.33% | -33.11% | +12.51% | -11.12% | +29.99% | +900.08% | +0% | +0% | +1,055.52% | ||
| 2017 | -50.00% | +0% | -5.00% | -23.67% | +20.67% | +127.27% | +44.58% | -4.34% | -4.55% | -11.43% | +7.32% | -54.91% | -43.75% |
Drawdown analysis of Bone Biologics (BBLG)
The maximum drawdown for the BBLG was -100.00%, occurring on Nov 20, 2025. This drawdown has not yet recovered.
The current BBLG drawdown is -100.00%.
Since Mar 31, 2016 BBLG has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Aug 30, 2018 | 1359 | Nov 20, 2025 | Ongoing | Ongoing | Ongoing |
| -91.36% | Aug 10, 2017 | 96 | Jan 30, 2018 | 102 | Aug 30, 2018 | 198 |
| -78.45% | Aug 8, 2016 | 102 | Jan 3, 2017 | 135 | Jul 18, 2017 | 237 |
| -2.00% | May 23, 2016 | 42 | Jul 22, 2016 | 11 | Aug 8, 2016 | 53 |